On April 18, 2018, Annual General Meeting of Molecular Partners AG, the shareholders of the company approved all motions proposed by the Board of Directors with a large majority and elected William (Bill) Burns as new Chairman of the Board. Bill held various executive positions at Roche for 28 years, culminating in his nomination to the position of CEO of Roche Pharmaceuticals and board seats at Roche, Genentech and Chugai Pharmaceuticals. The company will benefit from Bill's vast experience in the development and commercialization of drugs, particularly in oncology, and extensive knowledge of pharmaceutical industry operations. The shareholders also elected the three proposed members of the Nomination and Compensation Committee - Bill Burns, Göran Ando and William A. Lee.